Wednesday, September 7, 2011

30+ Life Science Investors/Partners Headed to Denver Sept 21-22

More than thirty of the industry’s leading investors and strategic partners will attend presentations by the region’s most innovative life science companies at the 2011 Rocky Mountain Life Science Investor and Partnering Conference (RMLIPC), September 21-22 at the Brown Palace Hotel, Denver. The announcement is made by Holli Riebel (formerly Baumunk), President and CEO of the Colorado BioScience Association (CBSA) who says, “Leading biotech, device, diagnostic and pharma investors from across the country and world will be coming to Denver to create the newest deals and shape the future landscape of the life science industry.”

The conference will present a strong slate of Rocky Mountain region companies to the investors. Thirty-one companies were selected to present from over fifty applicants spanning a range of sectors within the industry.

Apposite Capital, London, England -
BioVentures, Wellesley, MA -
Boston Equity Advisors, Canton, MA -
Boulder Ventures, Boulder, CO -
Bristol-Myers Squibb, New York, NY -
Canaan Partners, Menlo Park, CA -
Charter Life Sciences, Santa Clara, CA -
Covidien, Mansfield, MA -
CSU Ventures, Fort Collins, CO -
Delphi Ventures, Menlo Park, CA -
Doremus Advisory Services, New York, NY
Draper Fisher Jurvetson, Menlo Park, CA -
Frontier Angels, Polson, MT -
High Country Venture, Boulder, CO -
Johnson & Johnson, New Brunswick, NJ -
Longitude Capital, Menlo Park, CA -
Lumira Capital, Palo Alto, CA -
MedImmune, Gaithersburg, MD -
Merck Ventures, Montvale, NJ -
Morgenthaler Ventures, Menlo Park, CA -
OK Life Sciences Fund, Tulsa, OK -
OnSet Ventures, Menlo Park, CA -
Red Script Ventures, Brunswick, NJ -
Research Corp BioVentures, Tucson, AZ -
Sanderling Ventures, San Mateo, CA -
Sevin Rosen Funds, Palo Alto, CA -
Sun Mountain Capital, Santa Fe, NM -
Takeda Ventures, Palo Alto, CA -
TPG Biotech, San Francisco, CA -
Volcano Capital, New York, NY -
vSpring Capital, Salt Lake City, UT -

Link to the Business Wire release

Link to the Pitch Engine Social Media Release

No comments:

Post a Comment